Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-05

FDA Approved: CALCIPOTRIENE — Supplemental Application (Mayne Pharma)

View source ↗

Summary

The FDA approved a supplemental application for CALCIPOTRIENE submitted by Mayne Pharma. The document does not specify the exact changes included in the supplem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Calcipotriene (calcipotriene)

Snippet

SUPPL AP for CALCIPOTRIENE (CALCIPOTRIENE)